Putnam Investments LLC Arbutus Biopharma Corp Transaction History

Putnam Investments LLC

  • $73 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.98 - $3.17 $282,500 - $452,286
-142,677 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.42 - $3.98 $22,672 - $37,288
-9,369 Reduced 6.16%
142,677 $425,000
Q4 2021

Feb 14, 2022
BUY
$3.11 - $4.61 $472,863 - $700,932
152,046 New
152,046 $592,000

Others Institutions Holding ABUS

# of Institutions
155
Shares Held
99.5M
Call Options Held
2.31M
Put Options Held
525K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $478M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email